Cite Filings / VOR / 0001415889-25-024456

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Vor Biopharma Inc. Filed 2025-09-12 Acc 0001415889-25-024456

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-09-19 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-15 4 10% owner sold 984,805 shares at an average $1.73 ($1,703,971)
2025-09-12 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-10 4 10% owner sold 1,263,647 shares at an average $1.95 ($2,457,975)
2025-09-10 4 Options or other derivatives
2025-09-10 4 Options or other derivatives
2025-09-09 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…